Asma Jabeen, Umar Ali Khan, Ghulam Mustafa Lodhi


Background: The incidence of obesity is increasing worldwide. The lipid derangements and decrease in
nerve conduction velocity are important complications for which a number of treatment options are
being considered. In this study, Simvastatin, a hydroxyl methyl glutaryl coenzyme A reductase inhibitor
is studied for its effects on these complications of obesity. Methods: The study was a randomised
control trial conducted at Islamic International Medical College, Rawalpindi in collaboration with
Railway General Hospital, Rawalpindi, and National Institute of Health, Islamabad. Ninety adult male
Sprague Dawley rats were divided into three groups with thirty rats in each group. One group of rats was
taken as control with normal diet while other two groups were given High Fat Diet (HFD) for the whole
study period, i.e., 10 weeks. One of the HFD group was given Simvastatin along with high fat diet for
four weeks. Lipid profile was done by enzymatic colorimetric method. Conduction velocity of sciatic
nerve was determined with the help of PowerLab® data acquisition system. Results: The two groups
with HFD showed more than 25% increase in weight at the end of study as compared to control group.
HFD group showed significantly higher lipid profile and decreased sciatic nerve conduction velocity
when compared with control. The group that was given Simvastatin showed significant improvement in
lipid profile and increased sciatic nerve conduction velocity after 4 weeks when compared with the group
that was given HFD without any intervention. Conclusions: Simvastatin is effective for improving the
lipid profile and sciatic nerve conduction velocity in HFD induced obesity.
Keywords: Obesity, Simvastatin, nerve conduction velocity

Full Text:



Eckersley ME, Losing the battle of the bulge: causes and

consequences of increasing obesity. Med J Aust 2001;174:590–2.

Pi-sunyer FX. The obesity epidemic: Pathophysiology and

consequences of obesity. Obes Res 2002;10:97S–104S.

Shafi S, Rao MH, Soomro IB. The effect of life style and socioeconomic factors in the development of obesity in young adults.

Pak J Med Res 2004;43(2):65–9.

Bhatti MS, Akbri MZ, Shakoor M .Lipid Profile in Obesity. J

Ayub Med Coll Abbottabad. 2001;13:31–3.

Knobler H, Malnick SDH. The medical complications of obesity.

Q J Med 2006;99:565–79.

Nishikawa S, Yasoshima A, Doi K, Nakayama H, Uetsuka K.

Involvement of Sex, strain and age factors in high fat diet

induced obesity in C-57BL/6J and BALB/cA mice. Exp Anim


Becker J, Nora DB, Gomes I, String FF, Seitensus R, Panosso JS,

Cehlers JA. An evaluation of gender, obesity, age and diabetes

mellitus as risk factors for carpal tunnel syndrome. Clin

Neurophysiol 2002;113:1429–34.

Grundy SM, Barnett JP. Metabolic and health complications of

obesity. Dis Mon 1990;36:641–731.

J Ayub Med Coll Abbottabad 2011;23(3)

http://www.ayubmed.edu.pk/JAMC/23-3/Jabeen.pdf 39

Datillo AM, Kris-Etherton PM. Effects of weight reduction on

blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr

;56:320– 8.

Miscio G, Guastamacchia G, Brunani A, Priano L, Baudo S,

Mauro A. Obesity and peripheral neuropathy risk: a dangerous

liaison. J Peripher Nerv Syst 2005;10:354– 8.

Oltman CL, Coppey LJ, Gellett JS, Davidson EP, Lund DD,

Yorek MA. Progression of vascular and neural dysfunction in

sciatic nerves of Zucker diabetic fatty and Zucker rats. Am J

Physiol Endocrinal Metab 2005;289:113–22.

Sparrow CP, Burton CA, Hernandez M, Mundt S, Hassing H,

Patel S, et al. Simvastatin has anti-inflammatory and

antiatherosclerotic activities independent of plasma cholesterol

lowering. Arterioscler Thromb Vasc Biol 2001;21:115–21.

Tawfik HE, El-Remessy AB, Matragoon S, Ma G, Caldwell

RB, Caldwell RW. Simvastatin improves diabetes induced

coronary endothelial dysfunction. J Pharmacol Exp Ther


Jeon JR, Kim JY. Effect of Pine needle extract on differentiation

of 3T3-11 preadipocytes obesity in high fat diet fed rats. Biol

Pharm Bull 2006;29:2111–5.

Levin BE, Dunn-Meynell AA. Defense of body weight

depends on dietary composition and palatability in rats with

diet induced obesity. Am J Physiol Regul Integr Comp Physiol


Penumathsa SV, Thirunavukkarasu M, Koneru S, Juhasz B, Zhan

L, Pant R, et al. Statin and Resveratrol in combination induces

cardioprotection against myocardial infarction in

hypercholesterolemic rat. J Mol Cell Cardiol 2007;42:508–16.

Song G, Liu J, Zhao Z, Yu Y, Tian H, Yao S, et al. Simvastatin

reduces atherogenesis and promotes the expression of hepatic

genes associated with reverse cholesterol transport in apo Eknockout mice fed in high fat diet. Lipids Health Dis 2011;10:8.

Adameova A, Harcarova A, Matejikova J, Pancza D, Kuzelova

M, Carnicka S, et al. Simvastatin alleviates myocardial

contractile dysfunction and lethal ischemic injury in rat heart

independent of cholesterol lowering effect. Physiol Res


Collins R, Armitage T, Parish S, Peto R, Wallendszus K,

Bowman L, et al. Intensive loeringof LDL cholesterol with 80

mg versus 20 mg simvastatin daily in 12064 survivors of

myocardial infarction: a double blind randomized trial. Lancet


Obrosova IG, Inytska O, Lysogubov VV, Pavlov IA, Mashtalir

N, Nadler JL, et al. High fat diet induced neuropathy of prediabetes and obesity. Effects of ‘healthy’ diet and aldose

reductase inhibition. Diabetes 2007;56:2598– 608.

Sabri M, Jinglu A, Philip A, Marsden, Macdonald RL.

Simvastatin re-couples dysfunctional endothelial nitric oxide

synthase in experimental subarachnoid hemorrhage. PLoS One



  • There are currently no refbacks.

Contact Number: +92-992-382571

email: [jamc] [@] [ayubmed.edu.pk]